Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
Still, some companies do it a lot better than others—and successfully integrating acquisitions can spur strong growth and share-price jumps for their investors.
Stantec’s strategy of making small acquisitions is safer than making big purchases because any mistakes tend to be smaller....
RESMED INC....
CALIAN GROUP $47.00 (Toronto symbol CGY; TSINetwork Rating: Speculative) (613-599-8600; www.calian.com; Shares outstanding: 8.0 million; Market cap: $377.6 million; Dividend yield: 2.4%) has two main opertions: Business and Technology Services (contributing 70% of revenue) provides engineers, health-care workers and other skilled professionals on a contract basis; and Systems Engineering (30% of revenue) sells hardware and software for satellite and other communications systems.
In the quarter ended December 31, 2019, Calian’s revenue jumped 24.1%, to $99.2 million from $79.9 million a year earlier....
On January 31, 2020, 1Life sold 7.5 million shares of its stock to IPO investors at $14 a share....
Here are three aggressive stocks that we see as particularly attractive buys right now....